Development of KGF Antagonist as a Breast Cancer Therapeutic
Abstract
This grant proposal is to synthesize potential KGF antagonists which will then be evaluated for efficacy in in vitro assay systems. The results generated for the proposed study will be useful for designing new therapeutic agent for breast cancer. KGF antagonist candidate peptides have been synthesized and evaluated its ability. There is, however lack of sensitivity issue underlies on the functional assay procedure. We then developed several KGF-receptor overexpressed cell lines for further use. We are on the process to evaluate the cell lines.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2001
- Accession Number
- ADA405915
Entities
People
- Yasuro Sugimoto
Organizations
- Ohio State University